{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T20:06:33Z","timestamp":1785009993247,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2020A1515110791"],"award-info":[{"award-number":["2020A1515110791"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s10815-025-03488-4","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T15:31:10Z","timestamp":1746804670000},"page":"1939-1947","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Analysis of cumulative live birth rate outcomes of four ovarian stimulation protocols in Poseidon groups 3\/4 patients with adenomyosis"],"prefix":"10.1007","volume":"42","author":[{"given":"Jiayi","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajie","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7722-3366","authenticated-orcid":false,"given":"Rui","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"issue":"10","key":"3488_CR1","doi-asserted-by":"publisher","first-page":"102228","DOI":"10.1016\/j.jogoh.2021.102228","volume":"50","author":"M Bourdon","year":"2021","unstructured":"Bourdon M, et al. Adenomyosis: an update regarding its diagnosis and clinical features. J Gynecol Obstet Hum Reprod. 2021;50(10):102228.","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"1","key":"3488_CR2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12958-016-0185-6","volume":"14","author":"JM Puente","year":"2016","unstructured":"Puente JM, et al. Adenomyosis in infertile women: prevalence and the role of 3D ultrasound as a marker of severity of the disease. Reprod Biol Endocrinol. 2016;14(1):60.","journal-title":"Reprod Biol Endocrinol"},{"issue":"6","key":"3488_CR3","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.rbmo.2020.02.011","volume":"40","author":"H Abu Hashim","year":"2020","unstructured":"Abu Hashim H, et al. The prevalence of adenomyosis in an infertile population: a cross-sectional study. Reprod Biomed Online. 2020;40(6):842\u201350.","journal-title":"Reprod Biomed Online"},{"issue":"1","key":"3488_CR4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.rbmo.2020.09.023","volume":"42","author":"K Nirgianakis","year":"2021","unstructured":"Nirgianakis K, et al. Fertility, pregnancy and neonatal outcomes of patients with adenomyosis: a systematic review and meta-analysis. Reprod Biomed Online. 2021;42(1):185\u2013206.","journal-title":"Reprod Biomed Online"},{"key":"3488_CR5","doi-asserted-by":"publisher","first-page":"609771","DOI":"10.3389\/fendo.2021.609771","volume":"12","author":"J Lan","year":"2021","unstructured":"Lan J, et al. Ultra-long GnRH agonist protocol during IVF\/ICSI improves pregnancy outcomes in women with adenomyosis: a retrospective cohort study. Front Endocrinol (Lausanne). 2021;12:609771.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3488_CR6","first-page":"104620","volume":"82","author":"T Dian","year":"2022","unstructured":"Dian T, et al. Comparison of oocyte count, fertilization, and pregnancy rates in adenomyosis patients undergoing in vitro fertilization with short and long protocol controlled ovarian stimulation - Restospective study. Ann Med Surg (Lond). 2022;82:104620.","journal-title":"Ann Med Surg (Lond)"},{"issue":"12","key":"3488_CR7","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1093\/humrep\/des305","volume":"27","author":"V Thalluri","year":"2012","unstructured":"Thalluri V, Tremellen KP. Ultrasound diagnosed adenomyosis has a negative impact on successful implantation following GnRH antagonist IVF treatment. Hum Reprod. 2012;27(12):3487\u201392.","journal-title":"Hum Reprod"},{"key":"3488_CR8","doi-asserted-by":"publisher","first-page":"1198779","DOI":"10.3389\/fendo.2023.1198779","volume":"14","author":"L Ge","year":"2023","unstructured":"Ge L, et al. Effects of ovarian stimulation protocols on outcomes of assisted reproductive technology in adenomyosis women: a retrospective cohort study. Front Endocrinol (Lausanne). 2023;14:1198779.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"3488_CR9","first-page":"223","volume":"54","author":"S Ferrero","year":"2009","unstructured":"Ferrero S, et al. GnRH analogue remarkably down-regulates inflammatory proteins in peritoneal fluid proteome of women with endometriosis. J Reprod Med. 2009;54(4):223\u201331.","journal-title":"J Reprod Med"},{"issue":"2","key":"3488_CR10","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3109\/09513590.2012.730569","volume":"29","author":"IA Mohsen","year":"2013","unstructured":"Mohsen IA, El Din RE. Minimal stimulation protocol using letrozole versus microdose flare up GnRH agonist protocol in women with poor ovarian response undergoing ICSI. Gynecol Endocrinol. 2013;29(2):105\u20138.","journal-title":"Gynecol Endocrinol"},{"issue":"10","key":"3488_CR11","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1093\/humrep\/der240","volume":"26","author":"D Pu","year":"2011","unstructured":"Pu D, Wu J, Liu J. Comparisons of GnRH antagonist versus GnRH agonist protocol in poor ovarian responders undergoing IVF. Hum Reprod. 2011;26(10):2742\u20139.","journal-title":"Hum Reprod"},{"issue":"1","key":"3488_CR12","doi-asserted-by":"publisher","first-page":"30799","DOI":"10.1038\/s41598-024-81033-6","volume":"14","author":"H Yin","year":"2024","unstructured":"Yin H, et al. Assessment of ovarian reserve function in patients with adenomyosis and ovarian endometriosis by three-dimensional transvaginal ultrasound and anti-M\u00fcllerian hormone. Sci Rep. 2024;14(1):30799.","journal-title":"Sci Rep"},{"key":"3488_CR13","doi-asserted-by":"publisher","first-page":"1014519","DOI":"10.3389\/fendo.2022.1014519","volume":"13","author":"FA Gulino","year":"2022","unstructured":"Gulino FA, et al. Anti-Mullerian hormone (AMH) and adenomyosis: mini-review of literature of the last 5 years. Front Endocrinol (Lausanne). 2022;13:1014519.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"3488_CR14","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.fertnstert.2016.02.005","volume":"105","author":"C Alviggi","year":"2016","unstructured":"Alviggi C, et al. A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept. Fertil Steril. 2016;105(6):1452\u20133.","journal-title":"Fertil Steril"},{"issue":"10","key":"3488_CR15","doi-asserted-by":"publisher","first-page":"9354","DOI":"10.18632\/aging.103210","volume":"12","author":"F Li","year":"2020","unstructured":"Li F, et al. Efficacies of different ovarian hyperstimulation protocols in poor ovarian responders classified by the POSEIDON criteria. Aging (Albany NY). 2020;12(10):9354\u201364.","journal-title":"Aging (Albany NY)"},{"key":"3488_CR16","doi-asserted-by":"publisher","first-page":"644456","DOI":"10.3389\/fendo.2021.644456","volume":"12","author":"S Zhang","year":"2021","unstructured":"Zhang S, et al. Comparison of cumulative live birth rates between GnRH-A and PPOS in low-prognosis patients according to POSEIDON criteria: a cohort study. Front Endocrinol (Lausanne). 2021;12:644456.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3488_CR17","doi-asserted-by":"publisher","first-page":"938500","DOI":"10.3389\/fendo.2022.938500","volume":"13","author":"Z Li","year":"2022","unstructured":"Li Z, et al. Analysis of cumulative live birth rate and perinatal outcomes in young patients with low anti-m\u00fcllerian hormone levels using two ovulation promotion protocols: a cohort study. Front Endocrinol (Lausanne). 2022;13:938500.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"3488_CR18","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.fertnstert.2022.06.012","volume":"118","author":"H Chen","year":"2022","unstructured":"Chen H, et al. Comparison of the cumulative live birth rates after 1 in vitro fertilization cycle in women using gonadotropin-releasing hormone antagonist protocol vs. progestin-primed ovarian stimulation: a propensity score-matched study. Fertil Steril. 2022;118(4):701\u201312.","journal-title":"Fertil Steril"},{"key":"3488_CR19","doi-asserted-by":"publisher","first-page":"705264","DOI":"10.3389\/fendo.2021.705264","volume":"12","author":"M Du","year":"2021","unstructured":"Du M, et al. Comparison of the cumulative live birth rates of progestin-primed ovarian stimulation and flexible GnRH antagonist protocols in patients with low prognosis. Front Endocrinol (Lausanne). 2021;12:705264.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"3488_CR20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00404-020-05924-5","volume":"304","author":"J Guo","year":"2021","unstructured":"Guo J, et al. Clinical outcomes after single-versus double-embryo transfers in women with adenomyosis: a retrospective study. Arch Gynecol Obstet. 2021;304(1):263\u201370.","journal-title":"Arch Gynecol Obstet"},{"key":"3488_CR21","doi-asserted-by":"publisher","first-page":"263349412110620","DOI":"10.1177\/26334941211062026","volume":"16","author":"F Di Guardo","year":"2022","unstructured":"Di Guardo F, et al. Poor ovarian response and the possible role of natural and modified natural cycles. Ther Adv Reprod Health. 2022;16:26334941211062024.","journal-title":"Ther Adv Reprod Health"},{"issue":"3","key":"3488_CR22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/GCO.0000000000000452","volume":"30","author":"A Vaiarelli","year":"2018","unstructured":"Vaiarelli A, et al. What is new in the management of poor ovarian response in IVF? Curr Opin Obstet Gynecol. 2018;30(3):155\u201362.","journal-title":"Curr Opin Obstet Gynecol"},{"key":"3488_CR23","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3389\/fendo.2020.00318","volume":"11","author":"M Chen","year":"2020","unstructured":"Chen M, et al. Impact of gonadotropin-releasing hormone agonist pre-treatment on the cumulative live birth rate in infertile women with adenomyosis treated with IVF\/ICSI: a retrospective cohort study. Front Endocrinol (Lausanne). 2020;11:318.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"3488_CR24","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.rbmo.2021.10.014","volume":"44","author":"Y Wu","year":"2022","unstructured":"Wu Y, et al. Long-term GnRH agonist pretreatment before frozen embryo transfer improves pregnancy outcomes in women with adenomyosis. Reprod Biomed Online. 2022;44(2):380\u20138.","journal-title":"Reprod Biomed Online"},{"issue":"1","key":"3488_CR25","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.fertnstert.2015.03.022","volume":"104","author":"Y Kuang","year":"2015","unstructured":"Kuang Y, et al. Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril. 2015;104(1):62-70.e3.","journal-title":"Fertil Steril"},{"key":"3488_CR26","doi-asserted-by":"publisher","first-page":"1232935","DOI":"10.3389\/fendo.2023.1232935","volume":"14","author":"G Lin","year":"2023","unstructured":"Lin G, et al. The clinical value of progestin-primed ovarian stimulation protocol for women with diminished ovarian reserve undergoing IVF\/ICSI: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2023;14:1232935.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3488_CR27","doi-asserted-by":"publisher","first-page":"801026","DOI":"10.3389\/fendo.2021.801026","volume":"12","author":"X Tu","year":"2021","unstructured":"Tu X, et al. Progestin-primed ovarian stimulation versus mild stimulation protocol in advanced age women with diminished ovarian reserve undergoing their first in vitro fertilization cycle: a retrospective cohort study. Front Endocrinol (Lausanne). 2021;12:801026.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"3488_CR28","doi-asserted-by":"publisher","first-page":"e2939","DOI":"10.1097\/MD.0000000000002939","volume":"95","author":"Y Wang","year":"2016","unstructured":"Wang Y, et al. Controlled ovarian stimulation using medroxyprogesterone acetate and hMG in patients with polycystic ovary syndrome treated for IVF: a double-blind randomized crossover clinical trial. Medicine (Baltimore). 2016;95(9):e2939.","journal-title":"Medicine (Baltimore)"},{"key":"3488_CR29","doi-asserted-by":"publisher","first-page":"702558","DOI":"10.3389\/fendo.2021.702558","volume":"12","author":"S Guan","year":"2021","unstructured":"Guan S, et al. Progestin-primed ovarian stimulation protocol for patients in assisted reproductive technology: a meta-analysis of randomized controlled trials. Front Endocrinol (Lausanne). 2021;12:702558.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"3488_CR30","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1093\/humrep\/deaa068","volume":"35","author":"A La Marca","year":"2020","unstructured":"La Marca A, et al. Comparison of euploidy rates of blastocysts in women treated with progestins or GnRH antagonist to prevent the luteinizing hormone surge during ovarian stimulation. Hum Reprod. 2020;35(6):1325\u201331.","journal-title":"Hum Reprod"},{"issue":"3","key":"3488_CR31","doi-asserted-by":"publisher","first-page":"278","DOI":"10.4103\/jhrs.jhrs_85_22","volume":"15","author":"RK Khurana","year":"2022","unstructured":"Khurana RK, et al. Comparing progesterone primed ovarian stimulation (PPOS) to GnRH antagonist protocol in oocyte donation cycles. J Hum Reprod Sci. 2022;15(3):278\u201383.","journal-title":"J Hum Reprod Sci"},{"key":"3488_CR32","doi-asserted-by":"publisher","first-page":"581927","DOI":"10.3389\/fmed.2021.581927","volume":"8","author":"J Chen","year":"2021","unstructured":"Chen J, et al. PPOS Protocol effectively improves the IVF outcome without increasing the recurrence rate in early endometrioid endometrial cancer and atypical endometrial hyperplasia patients after fertility preserving treatment. Front Med (Lausanne). 2021;8:581927.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"3488_CR33","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12958-023-01124-3","volume":"21","author":"AH Pai","year":"2023","unstructured":"Pai AH, et al. Progestin Primed Ovarian Stimulation (PPOS) protocol yields lower euploidy rate in older patients undergoing IVF. Reprod Biol Endocrinol. 2023;21(1):72.","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"3488_CR34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13048-020-00620-z","volume":"13","author":"E Mathieu d'Argent","year":"2020","unstructured":"Mathieu d\u2019Argent E, et al. Outcomes of fertility preservation in women with endometriosis: comparison of progestin-primed ovarian stimulation versus antagonist protocols. J Ovarian Res. 2020;13(1):18.","journal-title":"J Ovarian Res"},{"key":"3488_CR35","doi-asserted-by":"publisher","first-page":"798434","DOI":"10.3389\/fendo.2022.798434","volume":"13","author":"AM Yang","year":"2022","unstructured":"Yang AM, et al. Progestin-primed ovarian stimulation protocol for patients with endometrioma. Front Endocrinol (Lausanne). 2022;13:798434.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"3488_CR36","doi-asserted-by":"publisher","first-page":"hoac009","DOI":"10.1093\/hropen\/hoac009","volume":"2022","author":"CM Becker","year":"2022","unstructured":"Becker CM, et al. ESHRE guideline: endometriosis. Hum Reprod Open. 2022;2022(2):hoac009.","journal-title":"Hum Reprod Open"},{"issue":"2","key":"3488_CR37","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ijgo.2007.08.021","volume":"100","author":"C Ma","year":"2008","unstructured":"Ma C, et al. Ovarian suppression treatment prior to in-vitro fertilization and embryo transfer in Chinese women with stage III or IV endometriosis. Int J Gynaecol Obstet. 2008;100(2):167\u201370.","journal-title":"Int J Gynaecol Obstet"},{"issue":"4","key":"3488_CR38","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S0015-0282(02)03373-3","volume":"78","author":"ES Surrey","year":"2002","unstructured":"Surrey ES, et al. Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis. Fertil Steril. 2002;78(4):699\u2013704.","journal-title":"Fertil Steril"},{"issue":"1","key":"3488_CR39","first-page":"Cd004635","volume":"2006","author":"HN Sallam","year":"2006","unstructured":"Sallam HN, et al. Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database Syst Rev. 2006;2006(1):Cd004635.","journal-title":"Cochrane Database Syst Rev"},{"key":"3488_CR40","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fendo.2020.00129","volume":"11","author":"H Guo","year":"2020","unstructured":"Guo H, et al. Efficacy of different progestins in women with advanced endometriosis undergoing controlled ovarian hyperstimulation for in vitro fertilization-a single-center non-inferiority randomized controlled trial. Front Endocrinol (Lausanne). 2020;11:129.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"3488_CR41","doi-asserted-by":"publisher","first-page":"169","DOI":"10.5653\/cerm.2016.43.3.169","volume":"43","author":"CW Park","year":"2016","unstructured":"Park CW, et al. Pregnancy rate in women with adenomyosis undergoing fresh or frozen embryo transfer cycles following gonadotropin-releasing hormone agonist treatment. Clin Exp Reprod Med. 2016;43(3):169\u201373.","journal-title":"Clin Exp Reprod Med"},{"issue":"5","key":"3488_CR42","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.rbmo.2020.07.027","volume":"41","author":"X Hou","year":"2020","unstructured":"Hou X, et al. The effect of adenomyosis on IVF after long or ultra-long GnRH agonist treatment. Reprod Biomed Online. 2020;41(5):845\u201353.","journal-title":"Reprod Biomed Online"},{"issue":"9","key":"3488_CR43","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jogoh.2017.09.007","volume":"46","author":"K Kolanska","year":"2017","unstructured":"Kolanska K, et al. Pregnancy outcomes after controlled ovarian hyperstimulation in women with endometriosis-associated infertility: GnRH-agonist versus GnRH-antagonist. J Gynecol Obstet Hum Reprod. 2017;46(9):681\u20136.","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"3488_CR44","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.2147\/DDDT.S162541","volume":"12","author":"S Guo","year":"2018","unstructured":"Guo S, et al. GnRH agonist improves pregnancy outcome in mice with induced adenomyosis by restoring endometrial receptivity. Drug Des Devel Ther. 2018;12:1621\u201331.","journal-title":"Drug Des Devel Ther"},{"issue":"3","key":"3488_CR45","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s43032-020-00308-1","volume":"28","author":"N Kay","year":"2021","unstructured":"Kay N, et al. TGF-\u03b21 neutralization improves pregnancy outcomes by restoring endometrial receptivity in mice with adenomyosis. Reprod Sci. 2021;28(3):877\u201387.","journal-title":"Reprod Sci"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-025-03488-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10815-025-03488-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-025-03488-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T10:02:44Z","timestamp":1751536964000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10815-025-03488-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["3488"],"URL":"https:\/\/doi.org\/10.1007\/s10815-025-03488-4","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,9]]},"assertion":[{"value":"5 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}